WallStreetZenWallStreetZen

NASDAQ: ACTU
Actuate Therapeutics Inc Stock Ownership - Who owns Actuate Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Actuate Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Bios Equity Cof LPDirector2025-06-2771,428$7.00
$500.00kBuy
Aaron Gl FletcherDirector2025-06-2771,428$7.00
$500.00kBuy
Leslie W. KreisDirector2025-06-2771,428$7.00
$500.00kBuy

1 of 1

ACTU insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ACTU insiders and whales buy or sell their stock.

ACTU Shareholders

What type of owners hold Actuate Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Aaron Gl Fletcher43.87%10,196,456$76.68MInsider
Bios Equity Cof LP43.87%10,196,456$76.68MInsider
Leslie W. Kreis43.87%10,196,456$76.68MInsider
Bios Capital Management LP43.24%10,049,996$75.58MInstitution
Voss Capital LP3.86%896,278$6.74MInstitution
Vanguard Group Inc1.36%316,010$2.38MInstitution
Blackrock Inc1.21%282,074$2.12MInstitution
Geode Capital Management LLC0.63%145,412$1.09MInstitution
Northern Trust Corp0.37%85,454$642.61kInstitution
State Street Corp0.21%49,895$375.21kInstitution

1 of 3

ACTU vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ACTU28.22%71.78%Net Buying
CRBP40.84%59.16%Net SellingNet Buying
ETHZ75.31%24.69%Net Buying
SABS35.08%64.92%Net BuyingNet Buying
VTGN45.78%54.22%Net Buying
View Top Biotech Stocks

Actuate Therapeutics Stock Ownership FAQ

Who owns Actuate Therapeutics?

Actuate Therapeutics (NASDAQ: ACTU) is owned by 51.74% institutional shareholders, 131.60% Actuate Therapeutics insiders, and 0.00% retail investors. Aaron Gl Fletcher is the largest individual Actuate Therapeutics shareholder, owning 10.20M shares representing 43.87% of the company. Aaron Gl Fletcher's Actuate Therapeutics shares are currently valued at $76.68M.

If you're new to stock investing, here's how to buy Actuate Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.